Methenamine

CHEMBL1201270 Phase 4 Đã phê duyệt Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
140.2 g/mol
LogP
0.3
Phase
4

An antibacterial agent converted to formaldehyde in acidic urine, used to prevent recurrent urinary tract infections (UTIs) in people prone to frequent bladder infections. It is not used to treat active infections.

Khối lượng phân tử

140,1900 g/mol

LogP

0,30

TPSA

13,00 Ų

Lipinski RO5

Đạt

Lĩnh vực điều trị

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Cấu trúc 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

C1N2CN3CN1CN(C2)C3

InChI

InChI=1S/C6H12N4/c1-7-2-9-4-8(1)5-10(3-7)6-9/h1-6H2

Molecular Formula

C6H12N4

HBD / HBA

- / 4

Liên kết có thể quay

0

Nguyên tử nặng

10

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Câu hỏi thường gặp

An antibacterial agent converted to formaldehyde in acidic urine, used to prevent recurrent urinary tract infections (UTIs) in people prone to frequent bladder infections. It is not used to treat active infections.

Yes, Methenamine is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1201270. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 4101. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Tuyên bố miễn trách y tế

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.